Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

CHATTEM SANOFI

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 16
  • 0 comments

FDA approve LEVOCETIRIZINE DIHYDROCHLORIDE

Comment Full text

AMNEAL PHARMS CO

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 23
  • 0 comments

FDA approve BOSENTAN

Comment Full text

HIKMA

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 25
  • 0 comments

FDA approve AZATHIOPRINE SODIUM

Comment Full text

HIKMA

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 22
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

HIKMA

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 22
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

CHIESI

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 18
  • 0 comments

FDA approve OCTREOTIDE ACETATE

Comment Full text

RECORDATI RARE

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 23
  • 0 comments

FDA approve PASIREOTIDE DIASPARTATE

Comment Full text

INVAGEN PHARMS

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 21
  • 0 comments

FDA approve LANREOTIDE ACETATE

Comment Full text

AMTA

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 20
  • 0 comments

FDA approve PROPRANOLOL HYDROCHLORIDE

Comment Full text

APOTEX

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 22
  • 0 comments

FDA approve EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Comment Full text
  • Previous
  • 307
  • 308
  • 309
  • 310
  • 311
  • Next

Search

News categories

  • Technical Exchange News(9990)
  • Event(412)
  • SEC News(169512)
  • FDA Approval(9401)
  • Company Report(721)
  • Business News(112908)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin